These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38745514)

  • 1. Interventional radiotherapy (brachytherapy) for re-irradiation of recurrent head and neck malignancies: oncologic outcomes and morbidity.
    Bussu F; Fionda B; Rigante M; Rizzo D; Loperfido A; Gallus R; De Luca LM; Corbisiero MF; Lancellotta V; Tondo A; D'Aviero A; Mattiucci GC; Kovacs G; Galli J; Tagliaferri L
    Acta Otorhinolaryngol Ital; 2024 May; 44(Suppl. 1):S28-S36. PubMed ID: 38745514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer.
    Rühle A; Sprave T; Kalckreuth T; Stoian R; Haehl E; Zamboglou C; Laszig R; Knopf A; Grosu AL; Nicolay NH
    Radiat Oncol; 2020 Apr; 15(1):81. PubMed ID: 32299456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton Beam Reirradiation for Recurrent Head and Neck Cancer: Multi-institutional Report on Feasibility and Early Outcomes.
    Romesser PB; Cahlon O; Scher ED; Hug EB; Sine K; DeSelm C; Fox JL; Mah D; Garg MK; Han-Chih Chang J; Lee NY
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):386-395. PubMed ID: 27084656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re-irradiation with interstitial pulsed-dose-rate brachytherapy for unresectable recurrent head and neck carcinoma.
    Strnad V; Lotter M; Kreppner S; Fietkau R
    Brachytherapy; 2014; 13(2):187-95. PubMed ID: 24211123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Image-guided interstitial high-dose-rate brachytherapy in the treatment of inoperable recurrent head and neck malignancies: An effective option of reirradiation.
    Tselis N; Karagiannis E; Kolotas C; Baghi M; Milickovic N; Zamboglou N
    Head Neck; 2017 Apr; 39(4):E61-E68. PubMed ID: 28170118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interstitial low-dose-rate brachytherapy as a salvage treatment for recurrent head-and-neck cancers: long-term results.
    Puthawala A; Nisar Syed AM; Gamie S; Chen YJ; Londrc A; Nixon V
    Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):354-62. PubMed ID: 11567809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvage prostate re-irradiation using high-dose-rate brachytherapy or focal stereotactic body radiotherapy for local recurrence after definitive radiation therapy.
    Mbeutcha A; Chauveinc L; Bondiau PY; Chand ME; Durand M; Chevallier D; Amiel J; Kee DL; Hannoun-Lévi JM
    Radiat Oncol; 2017 Mar; 12(1):49. PubMed ID: 28274241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes after definitive re-irradiation with 3D brachytherapy with or without external beam radiation therapy for vaginal recurrence of endometrial cancer.
    Ling DC; Vargo JA; Glaser SM; Kim H; Beriwal S
    Gynecol Oncol; 2019 Mar; 152(3):581-586. PubMed ID: 30600093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overlapping volumes in re-irradiation for head and neck cancer - an important factor for patient selection.
    Embring A; Onjukka E; Mercke C; Lax I; Berglund A; Bornedal S; Wennberg B; Friesland S
    Radiat Oncol; 2020 Jun; 15(1):147. PubMed ID: 32513217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salvage Re-irradiation With Single-modality Interstitial Brachytherapy for the Treatment of Recurrent Gynaecological Tumours in the Pelvis: A Multi-institutional Study.
    Raziee H; D'Souza D; Velker V; Barnes E; Taggar A; Mendez L; Leung E
    Clin Oncol (R Coll Radiol); 2020 Jan; 32(1):43-51. PubMed ID: 31402286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeat re-irradiation with interstitial HDR-brachytherapy for an in-field isolated nodal recurrence in a patient with HPV-positive squamous cell carcinoma of the head and neck.
    Kim JK; Hardy-Abeloos C; Purswani JM; Kamen E; Concert CM; Duckworth T; Tam M; Haas J; Rybstein M; Vaezi A; Jacobson A; Hu KS
    Brachytherapy; 2023; 22(4):503-511. PubMed ID: 36593130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of Re-irradiation using carbon ions for recurrent head and neck malignancies after carbon-ion radiotherapy.
    Hayashi K; Koto M; Ikawa H; Hagiwara Y; Tsuji H; Ogawa K; Kamada T
    Radiother Oncol; 2019 Jul; 136():148-153. PubMed ID: 31015117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re-irradiation Using Intensity-modulated Radiotherapy for Recurrent and Second Primary Head and Neck Cancer.
    Choi SH; Chang JS; Choi J; Park SH; Keum KC; Park KR; Lee CG
    Anticancer Res; 2018 May; 38(5):3165-3173. PubMed ID: 29715158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re-irradiation of recurrent head and neck cancers using pulsed reduced dose rate radiotherapy: An institutional series.
    Megahed R; Prabhu AV; Mack DP; Gholami S; Samanta S; Patel M; Lewis GD
    Oral Oncol; 2024 May; 152():106778. PubMed ID: 38555751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypofractionated accelerated CT-guided interstitial ¹⁹²Ir-HDR-Brachytherapy as re-irradiation in inoperable recurrent cervical lymphadenopathy from head and neck cancer.
    Tselis N; Ratka M; Vogt HG; Kolotas C; Baghi M; Baltas D; Fountzilas G; Georgoulias V; Ackermann H; Zamboglou N
    Radiother Oncol; 2011 Jan; 98(1):57-62. PubMed ID: 21129799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformal re-irradiation of recurrent and new primary head-and-neck cancer.
    Dawson LA; Myers LL; Bradford CR; Chepeha DB; Hogikyan ND; Teknos TN; Terrell JE; Wolf GT; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):377-85. PubMed ID: 11380224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors improving the outcome of patients re-irradiated with intensity-modulated radiotherapy (IMRT) for relapse or new head and neck cancer developed in irradiated areas.
    Ohnleiter T; Antoni D; Lefebvre F; Truntzer P; Schultz P; Burgy M; Borel C; Noël G
    Chin Clin Oncol; 2018 Dec; 7(6):60. PubMed ID: 30180748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvage high-dose-rate (HDR) brachytherapy for recurrent head-and-neck cancer.
    Hepel JT; Syed AM; Puthawala A; Sharma A; Frankel P
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1444-50. PubMed ID: 16029806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perioperative high-dose-rate brachytherapy (PHDRB) in previously irradiated head and neck cancer: Initial results of a Phase I/II reirradiation study.
    Martínez-Monge R; Alcalde J; Concejo C; Cambeiro M; Garrán C
    Brachytherapy; 2006; 5(1):32-40. PubMed ID: 16563995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of HPV status in the re-irradiation of recurrent and second primary cancers of the head and neck.
    Velez MA; Wang PC; Hsu S; Chin R; Beron P; Abemayor E; St John M; Chen AM
    Am J Otolaryngol; 2018; 39(3):257-260. PubMed ID: 29433815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.